Home > Insider Trading > Filing (0001140361-23-012884)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305253	Eiger Biopharmaceuticals Inc.	EIGR	Biological Products, (No Disgnostic Substances) (2836)	361004130

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686952	Iii C. Eldon Mayer	C/O Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306	Ex Vp & Chief Commerc. Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-03-17	2,520	$1.07	57,948	No	4	S	Direct
Common Stock	Disposition	2023-03-17	1,875	$1.07	56,073	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units ("RSUs") granted on March 11, 2022 for 16,000 shares.
These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 12, 2021 for 11,875 shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.07 to $1.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.